Lack of correlation between Myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1139-1144

  Csont, Tamás ^a   Páli, Tibor ^a   Szilvássy, Zoltán ^a   Ferdinandy, Péter ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cGMP; Electron spin resonance; NG nitro L arginine; Nitric oxide; Nitroglycerin; Tolerance

Indexed keywords

CYCLIC GMP; GLYCERYL TRINITRATE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; ELECTRON SPIN RESONANCE; HEART MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SPIN TRAPPING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345164451     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00167-1     Document Type: Article

References (25)

1. Harrison DG and Bates JN, The nitrovasodilators. New ideas about old drugs. Circulation 87: 1461-1467, 1993.
2. Chung SJ and Fung HL, Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development. Biochem Pharmacol 45: 157-163, 1993.
3. Moncada S, Palmer RM and Higgs EA, Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
4. Schulz R. and Triggle CR, Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 15: 255-259, 1994.
5. Bassenge E and Zanzinger J, Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function. Am J Cardiol 70: 23B-29B, 1992.
6. Ferdinandy P, Szilvassy Z, Csont T, Csonka C, Nagy E, Koltai M and Dux L, Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol 115: 1129-1131, 1995.
7. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J and Koltai M, icular overdrive pacing-induced anti-ischemic effect: A conscious rabbit model of preconditioning. Am J Physiol 266: H2033-H2041, 1994.
8. Ferdinandy P, Szilvassy Z, Balogh N, Csonka C, Csont T, Koltai M and Dux L, Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann NY Acad Sci 793: 489-493, 1996.
9. Curtis MJ and Pabla R, Nitric oxide supplementation or synthesis block - Which is the better approach to treatment of heart disease? Trends Pharmacol Sci 18: 239-244, 1997.
10. Silver PJ, Pagani ED, de Garavilla L, van Aller GS, Volberg ML, Pratt PF and Buchholz RA, Reversal of nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast. Eur Pharmacol 199: 141-142, 1991.
11. Bouma P, Ferdinandy P, Sipkema P, Allaart CP and Westerhof N, Nitric oxide is an important determinant of coronary flow in the isolated blood perfused rat heart. Basic Res Cardiol 87: 570-584, 1992.
12. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Szilvassy J, Nagy I, Lonovics J and Koltai M, Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin. Br J Pharmacol 112: 999-1001, 1994.
13. Zweier JL, Wang P and Kuppusamy P, Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270: 304-307, 1995.
14. Ferdinandy P, Csont T, Csonka C, Török M, Dux M, Nemeth J, Horvath LI, Dux L, Szilvassy Z and Jancso G, Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: Role of nitric oxide and CGRP? Naunyn Schmiedebergs Arch Pharmacol 356: 356-363, 1997.
15. Mülsch A, Mordvintcev P and Vanin A, Quantification of nitric oxide in biological samples by electron spin resonance spectroscopy. Neuroprot 1: 165-173, 1992.
16. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyörgyi R, Nagy I, Koltai M and Dux L, Loss of pacing-induced preconditioning in rat hearts: Role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 29: 3321-3333, 1997.
17. Wallenstein S, Zucker CL and Fleiss JL, Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980.
18. Laursen JB, Mulsch A, Boesgaard S, Mordvintcev P, Trautner S, Gruhn N, Nielsen-Kudsk JE, Busse R and Aldershvile J, In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation 94: 2241-2247, 1996.
19. Salvemini D, Pistelli A and Vane J, Conversion of glycerol trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells. Br J Pharmacol 108: 162-169, 1993.
20. Torfgard K, Ahlner J, Axelsson KL, Norlander B and Bertler A, Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect of tolerance development. Can J Physiol Pharmacol 69: 1257-1261, 1991.
21. Lamontagne D, Pohl U and Busse R, The mechanical activity of the heart stimulates endothelium-derived relaxing factor release in the coronary vascular bed. J Cardiovasc Pharmacol 17: S89-S94, 1991.
22. Kojda G, Brixius K, Kottenberg K, Nix P, Schluter KD, Piper HM and Noack E, The new NO donor SPM3672 increases cGMP and improves contraction in rat cardiomyocytes and isolated heart. Eur J Pharmacol 284: 315-319, 1995.
23. Kojda G, Kottenberg K, Nix P, Schlüter KD, Piper HM and Noack E, Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101, 1996.
24. Torfgard K, Ahlner J, Axelsson KL, Norlander B and Bertler A, Tissue distribution of glyceryl trinitrate and the effect on cGMP levels in rat. Pharmacol Toxicol 64: 369-372, 1989.
25. Hay-Yehia AI and Benet LZ, Dissociation of tissue thiol content from nitroglycerin-induced cyclic-3′,5′-guanosine monophosphate and the state of tolerance: In vivo experiments in rats. J Pharmacol Exp Ther 273: 94-100, 1995.